Characterization of laryngopharyngeal reflux in patients with premalignant or early carcinomas of the larynx

Cancer

Volumn 97, Issue 4, 2003, Pages 1010-1014

  Lewin, Jan S ^a   Gillenwater, Ann M ^a   Garrett, J David ^b   Bishop Leone, Julie K ^a   Nguyen, Dominic D ^a   Callender, David L ^a   Ayers, Gregory D ^a   Myers, Jeffrey N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR UNIVERSITY   (United States)

Author keywords

Gastroesophageal reflux; Laryngeal carcinogenesis; Laryngopharyngeal reflux; Larynx; pH probe; Reflux

Indexed keywords

ADULT; AGED; ARTICLE; BODY POSITION; CANCER INCIDENCE; CANCER STAGING; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEARTBURN; HISTOLOGY; HUMAN; LARYNGOPHARYNGEAL REFLUX; LARYNX CARCINOMA; MALE; PH MEASUREMENT; PRECANCER; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK FACTOR; SMOKING;

CARCINOMA; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; HYDROGEN-ION CONCENTRATION; LARYNGEAL NEOPLASMS; LARYNX; MALE; PHARYNX; PILOT PROJECTS; POSTURE; PRECANCEROUS CONDITIONS; SMOKING;

EID: 0037441625     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11158     Document Type: Article

References (13)

1. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsinin the development of laryngeal injury. Laryngoscope. 1991; 101:1-78.
2. Freije JE, Beatty TW, Campbell BH, Woodson BH, Schultz CJ, Toohill RJ. Carcinoma of the larynx in patients with gastroesophageal reflux. Am J Otolaryngol. 1996;17:386-390.
3. Lippman SM, Hong WK. Chemotherapy and chemoprevention. In: Myers EN, Suen JY, editors. Cancer of the head and neck, 3rd ed. Philadelphia: W. B. Saunders Company, 1996: 782-804.
4. Winters C Jr., Spurling TJ, Chobanian SJ, et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology. 1987;92:118-24.
5. Postma GN. Ambulatory pH monitoring methodology. Ann Otol Rhinol Laryngol Suppl. 2000;184:10-14.
6. Little JP, Matthews BL, Glock MS, et al. WF. Extraesophageal pediatric reflux: 24-hour double-probe pH monitoring of 222 children. Ann Otol Rhinol Laryngol Suppl. 1997;169:1-16.
7. Walner DL, Stern Y, Gerber ME, Rudolph C, Baldwin CY, Cotton RT. Gastroesophageal reflux in patients with subglottic stenosis. Arch Otolaryngol Head Neck Surg. 1998;124: 551-555.
8. Vincent DA, Garrett JD, Radionoff SL, Reussner LA, Stasney CR. The proximal probe in esophageal pH monitoring: development of a normative database. J Voice. 2000;14:247-254.
9. Bove M, Ruth M, Cange L, Mansson I. 24-H pharyngeal pH monitoring in healthy volunteers: a normative study. Scand J Gastroenterol. 2000;35:234-241.
10. Copper MP, Smit CF, Stanojcic LD, Devriese PP, Schouwenburg PF, Mathus-Vliegen LM. High incidence of laryngopharyngeal reflux in patients with head and neck cancer. Laryngoscope. 2000;110:1007-1011.
11. Gaynor EB. Otolaryngologic manifestations of gastroesophageal reflux. Am J Gastroenterol. 1991;86:801-808.
12. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825-831.
13. Bain WM, Harrington JW, Thomas LE, Schaefer SD. Head and neck manifestations of gastroesophageal reflux. Laryngoscope. 1983;93:175-179.